315 related articles for article (PubMed ID: 19375383)
21. HPV genotype prevalence in cervical specimens with abnormal cytology: a report from north-east Italy.
Rassu M; Bertoloni G; Mengoli C; Peron A; Benedetti P; Palu' G
Scand J Infect Dis; 2005; 37(6-7):476-81. PubMed ID: 16012008
[TBL] [Abstract][Full Text] [Related]
22. Type-specific reproducibility of the Roche linear array HPV genotyping test.
Steinau M; Swan DC; Unger ER
J Clin Virol; 2008 Aug; 42(4):412-4. PubMed ID: 18424229
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus detection and typing in thin prep cervical cytologic specimens comparing the Digene Hybrid Capture II Assay, the Roche Linear Array HPV Genotyping Assay, and the Kurabo GeneSquare Microarray Assay.
Ermel A; Qadadri B; Morishita A; Miyagawa I; Yamazaki G; Weaver B; Tu W; Tong Y; Randolph M; Cramer H; Brown D
J Virol Methods; 2010 Oct; 169(1):154-61. PubMed ID: 20670658
[TBL] [Abstract][Full Text] [Related]
24. Prevalence and genotype identification of human papillomavirus in women undergoing voluntary cervical cancer screening in Molise, central Italy.
Ripabelli G; Grasso GM; Del Riccio I; Tamburro M; Sammarco ML
Cancer Epidemiol; 2010 Apr; 34(2):162-7. PubMed ID: 20080070
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.
Kulmala SM; Shabalova IP; Petrovitchev N; Syrjänen KJ; Gyllensten UB; Syrjänen SM;
J Med Virol; 2007 Jun; 79(6):771-81. PubMed ID: 17457909
[TBL] [Abstract][Full Text] [Related]
26. [Human papilloma virus DNA in cervical samples with cytological abnormalities and typing of the virus].
Ergünay K; Misirlioğlu M; Pinar F; Tuncer ZS; Tuncer S; Ustaçelebi S
Mikrobiyol Bul; 2007 Apr; 41(2):219-26. PubMed ID: 17682708
[TBL] [Abstract][Full Text] [Related]
27. New approach to human high-risk papillomavirus (HR-HPV) genotyping.
Weismanová E; Weismann P; Vizváryová M; Lehotská V; Krizanová O; Repiská V; Kausitz J
Neoplasma; 2002; 49(4):217-24. PubMed ID: 12382018
[TBL] [Abstract][Full Text] [Related]
28. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the SPF10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test.
van Hamont D; van Ham MA; Bakkers JM; Massuger LF; Melchers WJ
J Clin Microbiol; 2006 Sep; 44(9):3122-9. PubMed ID: 16954236
[TBL] [Abstract][Full Text] [Related]
30. Characterization of human papillomavirus infection in north Taiwan.
Wang CH; Garvilles RG; Chen CY
J Med Virol; 2010 Aug; 82(8):1416-23. PubMed ID: 20572075
[TBL] [Abstract][Full Text] [Related]
31. Confirmation and quantitation of human papillomavirus type 52 by Roche Linear Array using HPV52-specific TaqMan E6/E7 quantitative real-time PCR.
Marks M; Gupta SB; Liaw KL; Kim E; Tadesse A; Coutlee F; Sriplienchan S; Celentano DD; Gravitt PE
J Virol Methods; 2009 Mar; 156(1-2):152-6. PubMed ID: 19022296
[TBL] [Abstract][Full Text] [Related]
32. comparison of two commercial assays for detection of human papillomavirus (HPV) in cervical scrape specimens: validation of the Roche AMPLICOR HPV test as a means to screen for HPV genotypes associated with a higher risk of cervical disorders.
van Ham MA; Bakkers JM; Harbers GK; Quint WG; Massuger LF; Melchers WJ
J Clin Microbiol; 2005 Jun; 43(6):2662-7. PubMed ID: 15956381
[TBL] [Abstract][Full Text] [Related]
33. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings.
Bruni L; Diaz M; Castellsagué X; Ferrer E; Bosch FX; de Sanjosé S
J Infect Dis; 2010 Dec; 202(12):1789-99. PubMed ID: 21067372
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of high-risk human papillomavirus type 16/18 infection among women with normal cytology: risk factor analysis and implications for screening and prophylaxis.
Gupta S; Sodhani P; Sharma A; Sharma JK; Halder K; Charchra KL; Sardana S; Singh V; Sehgal A; Das BC
Cytopathology; 2009 Aug; 20(4):249-55. PubMed ID: 19018810
[TBL] [Abstract][Full Text] [Related]
35. Easy and fast detection and genotyping of high-risk human papillomavirus by dedicated DNA microarrays.
Albrecht V; Chevallier A; Magnone V; Barbry P; Vandenbos F; Bongain A; Lefebvre JC; Giordanengo V
J Virol Methods; 2006 Nov; 137(2):236-44. PubMed ID: 16879879
[TBL] [Abstract][Full Text] [Related]
36. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
37. Epidemiology and genotype distribution of human papillomavirus (HPV) in women of Sardinia (Italy).
Masia G; Mazzoleni AP; Contu G; Laconi S; Minerba L; Montixi S; Montis F; Onano A; Porcedda E; Coppola RC
Vaccine; 2009 May; 27 Suppl 1():A11-6. PubMed ID: 19480954
[TBL] [Abstract][Full Text] [Related]
38. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
Eder PS; Lou J; Huff J; Macioszek J
J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
[TBL] [Abstract][Full Text] [Related]
39. Comparison of molecular assays for detection and typing of human papillomavirus.
Koidl C; Bozic M; Hadzisejdic I; Grahovac M; Grahovac B; Kranewitter W; Marth E; Kessler HH
Am J Obstet Gynecol; 2008 Aug; 199(2):144.e1-6. PubMed ID: 18439557
[TBL] [Abstract][Full Text] [Related]
40. Detection of human papillomavirus infection in women attending a colposcopy clinic.
Selva L; Gonzalez-Bosquet E; Rodriguez-Plata MT; Esteva C; Suñol M; Muñoz-Almagro C
Diagn Microbiol Infect Dis; 2009 Aug; 64(4):416-21. PubMed ID: 19376675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
